Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
JAMA Dermatology|April 16, 2025
Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the USBenjamin N Rome, Jihye Han, Helen Mooney, et al.Health Affairs (Project Hope)|August 4, 2025
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price NegotiationsDaniel A Ollendorf, Leah Z Rand, Alessandra Blonda, et al.Drugs|March 15, 2012
The cost effectiveness of human papillomavirus vaccines: a systematic reviewKatherine Seto, Fawziah Marra, Adam Raymakers, et al.American Heart Journal|December 28, 2020
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort studyBenjamin N Rome, Joshua J Gagne, Jerry Avorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2022
Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny LabelingBryan S Walsh, Aaron S Kesselheim, Ameet Sarpatwari, et al.Pediatrics|June 9, 2026
Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum DisordersBenjamin N Rome, John Kim, Jose F Figueroa, et al.Pharmacoepidemiology and Drug Safety|October 13, 2024
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded IndicationsAnjali D Deshmukh, Aaron S Kesselheim, Theodore Tsacogianis, et al.JAMA Internal Medicine|March 9, 2026
Cost-Related Medication Nonadherence After the Inflation Reduction ActLucas X Marinacci, Stephen Mein, Benjamin N Rome, et al.JAMA Internal Medicine|August 18, 2025
Changes in Medicare Part D Plan Designs After the Inflation Reduction ActChristopher L Cai, Anushka Bhaskar, Aaron S Kesselheim, et al.Journal of Cancer Policy|May 13, 2022
Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015-2020Kristina Jenei, Adam Raymakers, Daniel E Meyers, et al.Pageof 11